These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31208248)
1. Evaluation of Luminogenic Substrates as Probe Substrates for Bacterial Cytochrome P450 Enzymes: Application to Ortega Ugalde S; Ma D; Cali JJ; Commandeur JNM SLAS Discov; 2019 Aug; 24(7):745-754. PubMed ID: 31208248 [TBL] [Abstract][Full Text] [Related]
2. Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets? Ortega Ugalde S; Boot M; Commandeur JNM; Jennings P; Bitter W; Vos JC Appl Microbiol Biotechnol; 2019 May; 103(9):3597-3614. PubMed ID: 30810776 [TBL] [Abstract][Full Text] [Related]
3. Functional redundancy of steroid C26-monooxygenase activity in Mycobacterium tuberculosis revealed by biochemical and genetic analyses. Johnston JB; Ouellet H; Ortiz de Montellano PR J Biol Chem; 2010 Nov; 285(47):36352-60. PubMed ID: 20843794 [TBL] [Abstract][Full Text] [Related]
4. Linking cytochrome P450 enzymes from Mycobacterium tuberculosis to their cognate ferredoxin partners. Ortega Ugalde S; de Koning CP; Wallraven K; Bruyneel B; Vermeulen NPE; Grossmann TN; Bitter W; Commandeur JNM; Vos JC Appl Microbiol Biotechnol; 2018 Nov; 102(21):9231-9242. PubMed ID: 30136203 [TBL] [Abstract][Full Text] [Related]
5. Substrate analog studies of the ω-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1. Johnston JB; Singh AA; Clary AA; Chen CK; Hayes PY; Chow S; De Voss JJ; Ortiz de Montellano PR Bioorg Med Chem; 2012 Jul; 20(13):4064-81. PubMed ID: 22647881 [TBL] [Abstract][Full Text] [Related]
7. Luminogenic cytochrome P450 assays. Cali JJ; Ma D; Sobol M; Simpson DJ; Frackman S; Good TD; Daily WJ; Liu D Expert Opin Drug Metab Toxicol; 2006 Aug; 2(4):629-45. PubMed ID: 16859410 [TBL] [Abstract][Full Text] [Related]
8. A comparison of steroid and lipid binding cytochrome P450s from Mycobacterium marinum and Mycobacterium tuberculosis. Child SA; Ghith A; Bruning JB; Bell SG J Inorg Biochem; 2020 Aug; 209():111116. PubMed ID: 32473484 [TBL] [Abstract][Full Text] [Related]
9. Bioluminescent assays for ADME evaluation: dialing in CYP selectivity with luminogenic substrates. Cali JJ; Ma D; Wood MG; Meisenheimer PL; Klaubert DH Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1115-30. PubMed ID: 22686499 [TBL] [Abstract][Full Text] [Related]
10. [Research progresses of Mycobacterium tuberculosis cytochrome P450s as a potential drug target]. Lu Y; Qiao F; You XF; Yang XY Yao Xue Xue Bao; 2014 Apr; 49(4):427-34. PubMed ID: 24974457 [TBL] [Abstract][Full Text] [Related]
12. Engineering a self-sufficient Mycobacterium tuberculosis CYP130 by gene fusion with the reductase-domain of CYP102A1 from Bacillus megaterium. Ortega Ugalde S; Luirink RA; Geerke DP; Vermeulen NPE; Bitter W; Commandeur JNM J Inorg Biochem; 2018 Mar; 180():47-53. PubMed ID: 29232638 [TBL] [Abstract][Full Text] [Related]
13. Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis. McLean KJ; Munro AW Drug Metab Rev; 2008; 40(3):427-46. PubMed ID: 18642141 [TBL] [Abstract][Full Text] [Related]
15. The catalytic activity and structure of the lipid metabolizing CYP124 cytochrome P450 enzyme from Mycobacterium marinum. Ghith A; Bruning JB; Bell SG Arch Biochem Biophys; 2023 Mar; 737():109554. PubMed ID: 36842492 [TBL] [Abstract][Full Text] [Related]
16. Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1. Chenge JT; Duyet LV; Swami S; McLean KJ; Kavanagh ME; Coyne AG; Rigby SE; Cheesman MR; Girvan HM; Levy CW; Rupp B; von Kries JP; Abell C; Leys D; Munro AW J Biol Chem; 2017 Jan; 292(4):1310-1329. PubMed ID: 27932461 [TBL] [Abstract][Full Text] [Related]
17. The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention. McLean KJ; Belcher J; Driscoll MD; Fernandez CC; Le Van D; Bui S; Golovanova M; Munro AW Future Med Chem; 2010 Aug; 2(8):1339-53. PubMed ID: 21426022 [TBL] [Abstract][Full Text] [Related]
18. The preponderance of P450s in the Mycobacterium tuberculosis genome. McLean KJ; Clift D; Lewis DG; Sabri M; Balding PR; Sutcliffe MJ; Leys D; Munro AW Trends Microbiol; 2006 May; 14(5):220-8. PubMed ID: 16581251 [TBL] [Abstract][Full Text] [Related]
19. Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1. Ouellet H; Kells PM; Ortiz de Montellano PR; Podust LM Bioorg Med Chem Lett; 2011 Jan; 21(1):332-7. PubMed ID: 21109436 [TBL] [Abstract][Full Text] [Related]
20. Roles of cysteine in the structure and metabolic function of Lu Y; Sun L; Pang J; Li C; Wang X; Hu X; Li G; Li X; Zhang Y; Wang H; Yang X; You X RSC Adv; 2022 Aug; 12(38):24447-24455. PubMed ID: 36128375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]